Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Multimedia

Headshot of Meilin Diaz-Paez, University of Miami, on a blue background underneath the PopHealth Perspectives logo.
Videos
09/01/2022
Maria Asimopoulos
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, describes what payers should know about patients...
Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, describes what payers should know about patients...
Meilin Diaz-Paez, MSN, APRN,...
09/01/2022
First Report Managed Care
Headshot of Daniel A Vorobiof, Belong.Life, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
08/30/2022
Maria Asimopoulos
Daniel A Vorobiof, MD, chief medical officer, Belong.Life, discusses the Belong.Life app's resources for patients with cancer as well as the recent addition of personalized tools for those with chronic myeloid leukemia.
Daniel A Vorobiof, MD, chief medical officer, Belong.Life, discusses the Belong.Life app's resources for patients with cancer as well as the recent addition of personalized tools for those with chronic myeloid leukemia.
Daniel A Vorobiof, MD, chief...
08/30/2022
Integrated Healthcare Executive
Headshot of Tanja Dowe, Debiopharm Innovation Fund SA, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
08/23/2022
Maria Asimopoulos
Tanja Dowe, CEO, Debiopharm Innovation Fund SA, discusses the partnership between Debiopharm and VeriSIM Life and how advancements in technology can speed up the drug development process.
Tanja Dowe, CEO, Debiopharm Innovation Fund SA, discusses the partnership between Debiopharm and VeriSIM Life and how advancements in technology can speed up the drug development process.
Tanja Dowe, CEO, Debiopharm...
08/23/2022
Integrated Healthcare Executive
Headshot of John Murray, Stryker, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
08/11/2022
Maria Asimopoulos
John Murray, senior director of government accounts, Stryker, discusses how placing innovative surgical technology in Veterans Affairs hospitals can improve care quality for veterans with arthritis.
John Murray, senior director of government accounts, Stryker, discusses how placing innovative surgical technology in Veterans Affairs hospitals can improve care quality for veterans with arthritis.
John Murray, senior director of...
08/11/2022
Veterans Health Today
Headshot of Adam Kittai, Ohio State University, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
06/30/2022
Maria Asimopoulos
Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, shares how second generation BTK inhibitors are changing treatment decisions in chronic lymphocytic leukemia, and adds what payers should keep in mind...
Adam Kittai, MD, hematologist and assistant professor of medicine, Ohio State University, shares how second generation BTK inhibitors are changing treatment decisions in chronic lymphocytic leukemia, and adds what payers should keep in mind...
Adam Kittai, MD, hematologist...
06/30/2022
First Report Managed Care
Petros Grivas, MD, Fred Hutchinson Cancer Center
Podcasts
06/22/2022
Petros Grivas, MD, shares results from the phase 2 TROPHY-U-01 trial evaluating the sacituzumab govitecan in combination with pembrolizumab for patients with metastatic urothelial cancer who progressed after platinum-based regimens.
Petros Grivas, MD, shares results from the phase 2 TROPHY-U-01 trial evaluating the sacituzumab govitecan in combination with pembrolizumab for patients with metastatic urothelial cancer who progressed after platinum-based regimens.
Petros Grivas, MD, shares...
06/22/2022
Oncology
Robert Jones, MD
Podcasts
06/21/2022
Robert Jones, MD, shares results and insights from the phase 2 ATLANTIS trial, evaluating maintenance cabozantinib following platinum-based chemotherapy for patients with metastatic urothelial carcinoma.
Robert Jones, MD, shares results and insights from the phase 2 ATLANTIS trial, evaluating maintenance cabozantinib following platinum-based chemotherapy for patients with metastatic urothelial carcinoma.
Robert Jones, MD, shares results...
06/21/2022
Oncology
Headshot of Shirley Lee, Preveta, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
05/23/2022
Maria Asimopoulos
Shirley Lee, CRNP-FNP, MPH, cofounder and vice president of clinical strategy, Preveta, shares how the pandemic impacted specialty care as well as how technology can close gaps for patients with complex conditions.
Shirley Lee, CRNP-FNP, MPH, cofounder and vice president of clinical strategy, Preveta, shares how the pandemic impacted specialty care as well as how technology can close gaps for patients with complex conditions.
Shirley Lee, CRNP-FNP, MPH,...
05/23/2022
Integrated Healthcare Executive
Headshot of Rachael Jones, Cotiviti, on a blue background underneath the PopHealth Perspectives logo.
Videos
05/13/2022
Maria Asimopoulos
Rachael Jones, senior vice president of performance analytics and quality, Cotiviti, shares how payers can use analytics, education, and incentives to support providers in improving care access and outcomes for vulnerable populations.
Rachael Jones, senior vice president of performance analytics and quality, Cotiviti, shares how payers can use analytics, education, and incentives to support providers in improving care access and outcomes for vulnerable populations.
Rachael Jones, senior vice...
05/13/2022
First Report Managed Care

Advertisement

Advertisement

Advertisement